Targeting PTEN in Colorectal Cancers

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Phosphatase and tensin homolog (PTEN) is a key tumor suppressor gene frequently altered in human cancers.
• PTEN regulates critical cellular processes including proliferation, apoptosis, and cell signaling, notably by dephosphorylating phosphoinositides and counteracting the Akt pathway.
• While PTEN mutations are less common in colorectal cancers, downregulation and functional inactivation through posttranslational modifications or mislocalization are prevalent.

Purpose of the Study:

• To review the regulatory mechanisms of PTEN expression, activity, and function in the context of cancer.
• To explore strategies for pharmacologically restoring wild-type PTEN function in colon cancer cells.
• To discuss small molecules targeting PTEN regulators and alternative methods to modulate PTEN activity.

Main Methods:

• Literature review of PTEN regulation and function in cancer.
• Analysis of PTEN's role in colorectal cancer, including genetic alterations and functional inactivation.
• Examination of therapeutic strategies aimed at restoring PTEN activity.

Main Results:

• PTEN inactivation in colorectal cancer occurs through downregulation, posttranslational modifications, and mislocalization, in addition to mutations.
• Restoring PTEN function can inhibit colon cancer cell growth and induce apoptosis.
• Small molecules and alternative strategies show potential for modulating PTEN activity and conformation.

Conclusions:

• Pharmacological restoration of PTEN function is a viable therapeutic strategy for colon cancer.
• Targeting PTEN regulators and modulating its activity could overcome PTEN inactivation in tumors.
• A personalized approach to PTEN restoration may be beneficial for colon cancer treatment.